Page last updated: 2024-12-05

1,2,3-trichlorobenzene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,2,3-Trichlorobenzene is a colorless to pale yellow liquid with a pungent odor. It is used as an intermediate in the synthesis of other chemicals, such as pesticides and herbicides. It is also used as a solvent and a heat transfer fluid. 1,2,3-Trichlorobenzene is a known environmental contaminant. It is toxic to aquatic life and can cause skin and eye irritation. It is also a potential human carcinogen. 1,2,3-Trichlorobenzene is studied because of its potential environmental and health effects. It is also studied because of its potential use in various industrial applications. 1,2,3-Trichlorobenzene can be synthesized by the chlorination of benzene. It can also be produced as a byproduct of the manufacture of other chemicals. 1,2,3-Trichlorobenzene is a persistent organic pollutant (POP). This means that it breaks down slowly in the environment and can accumulate in the food chain. It is also bioaccumulative, meaning that it can accumulate in the tissues of organisms over time. 1,2,3-Trichlorobenzene is regulated by various environmental agencies around the world. This is because of its potential environmental and health effects. 1,2,3-Trichlorobenzene has been found in air, water, and soil samples. It can enter the environment through industrial emissions, spills, and leaks. 1,2,3-Trichlorobenzene is a highly volatile compound. This means that it can easily evaporate into the air. It is also soluble in water. This means that it can easily dissolve in water and move through the environment. 1,2,3-Trichlorobenzene is a dense compound. This means that it is heavier than water. It will sink to the bottom of bodies of water and can accumulate in sediments.'
```

trichlorobenzene: commercial grade of trichlorobenzene containing 70% 1,2,4-trichlorobenzene & 30% 1,2,3-trichlorobenzene; see also record for 1,2,4-trichlorobenzene [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trichlorobenzene : Any member of the class of chlorobenzenes carrying three chloro substituents at unspecified positions. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

1,2,3-trichlorobenzene : A trichlorobenzene carrying chloro substituents at positions 1, 2 and 3. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6895
CHEMBL ID46557
CHEBI ID35289
SCHEMBL ID23239
MeSH IDM0418829

Synonyms (72)

Synonym
BIDD:ER0649
1,2,3-trichlorbenzol
CHEBI:35289 ,
nsc-43432
nsc43432
trichlorobenzene
vic-trichlorobenzene
1,6-trichlorobenzene
1,3-trichlorobenzene
benzene,2,3-trichloro-
1,2,6-trichlorobenzene
benzene, 1,2,3-trichloro-
inchi=1/c6h3cl3/c7-4-2-1-3-5(8)6(4)9/h1-3
87-61-6
1,2,3-trichlorobenzene
NCGC00091850-01
brn 0956882
einecs 201-757-1
hsdb 1502
nsc 43432
ccris 5944
ai3-15516
1,2,3-trichlorobenzene, 99%
1,2,3-trichlorobenzene, analytical standard
NCGC00091850-02
1,2,3-tcb
1,2,3-trichloro-benzene
CHEMBL46557
MLS002415671
smr001370869
T0377
EN300-83456
NCGC00091850-03
NCGC00091850-04
AKOS007930300
HMS3039D12
12002-48-1
tox21_202113
cas-87-61-6
tox21_300501
NCGC00259662-01
dtxsid8026193 ,
NCGC00254273-01
dtxcid706193
benzene, 1,2,3-trichloro-, radical ion(1-)
51703-47-0
unii-nur9777ik4
nur9777ik4 ,
ec 201-757-1
FT-0606226
FT-0606225
CK1107
trichlorobenzene, 1,2,3-
benzene, 1,2,3-trichloro
1,2,3-trichlorobenzene [hsdb]
1,2,3-trichlorobenzene [mi]
SCHEMBL23239
1,2-dichlorochlorobenzene
10-oxapalitic acid
3907-98-0
mfcd00000537
1,2,3-trichlorobenzene, pestanal(r), analytical standard
1,2,3-trichlorobenzene 1000 microg/ml in methanol
1,2,3-trichlorobenzene 10 microg/ml in acetonitrile
benzene, 1,2,3-trichloro-; 1,2,3-trichlorobenzene; 1,2,6-trichlorobenzene; nsc 43432; vic-trichlorobenzene
1,2,3-trichlorobenzene 100 microg/ml in isooctane
1,2,3-trichlorobenzene 10 microg/ml in cyclohexane
1,2,3-trichlorobenzene (d3)
1,2,3-trichlorobenzene 5000 microg/ml in methanol
Q1917053
56 - eqsd directive - low level organophosphorus & chlorinated solvents
109 - eqsd directive - low level organophosphorus & chlorinated solvents

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Toxic unit (TU) and additional index (AI) were introduced to determine the outcome in combined tests, and the coexistence of Cu, Cd, Cr(III) and p-chlorobenzene was antagonism, and the effect of Cu, Cd, Cr(III) and o-chlorobenzene, Cu and 1,2,4-trichlorobenzene were synergism."( Joint toxicity of heavy metals and chlorobenzenes to pyriformis Tetrahymena.
Li, X; Liu, P; Lu, Y; Luo, H; Zhang, C; Zhang, T, 2014
)
0.4
"Acute toxic effects of three typical organic pollutants 1 ,2,4-trichlorobenzene (1,2,4-TCB), nitrobenzene and chlorpyrifos were investigated using Tetrahymena thermophila and Limnodrilus hoffmeisteri as living test organisms under laboratory conditions."( [Acute Toxicity and Safety Assessment of Three Typical Organic Pollutants to Two Aquatic Organisms].
Cui, YB; Li, M; Li, YJ; Yang, Y, 2015
)
0.42

Compound-Compound Interactions

ExcerptReferenceRelevance
"The experiments on Wistar rats were undertaken to analyze metabolism of 253Pu in combination with tributylphosphate and organic solvents of trichlorobenzene and H-paraffin entering the organism through stab-wounds."( [Distribution of plutonium-239 in the bodies of rats after its administration together with tributyl phosphate combined with organic solvents].
Khalturin, GV; Kuz'menko, OV, 1989
)
0.28

Dosage Studied

ExcerptRelevanceReference
" There was a significant dose-response relationship between the TCB exposure and DNA strand breakage in the soybean nuclei."( Root growth inhibition and induction of DNA damage in soybean (Glycine max) by chlorobenzenes in contaminated soil.
Li, P; Liu, W; Sun, T; Yang, YS; Zhou, Q, 2004
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trichlorobenzeneAny member of the class of chlorobenzenes carrying three chloro substituents at unspecified positions.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency49.00890.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency67.75340.001530.607315,848.9004AID1224848; AID1224849
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.19270.000229.305416,493.5996AID743069
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency24.03980.000323.4451159.6830AID743065
gemininHomo sapiens (human)Potency0.20600.004611.374133.4983AID624297
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (16)

Assay IDTitleYearJournalArticle
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID603957Octanol-water partition coefficient, log P of the compound2008European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
AID159270Toxicity determined using Microtox Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
AID162229Toxicity determined using Konemann's Industrial Pollutants Toxicity Test1991Journal of medicinal chemistry, May, Volume: 34, Issue:5
Using theoretical descriptors in quantitative structure-activity relationships: some toxicological indices.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (93)

TimeframeStudies, This Drug (%)All Drugs %
pre-199016 (17.20)18.7374
1990's11 (11.83)18.2507
2000's31 (33.33)29.6817
2010's30 (32.26)24.3611
2020's5 (5.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.33

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.33 (24.57)
Research Supply Index4.56 (2.92)
Research Growth Index4.70 (4.65)
Search Engine Demand Index45.89 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.33)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.05%)6.00%
Case Studies1 (1.05%)4.05%
Observational0 (0.00%)0.25%
Other93 (97.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]